|
1
|
Chi HJ, Chen ML, Yang XC, Lin XM, Sun H,
Zhao WS, Qi D, Dong JL and Cai J: Progress in therapies for
myocardial ischemia reperfusion injury. Curr Drug Targets.
18:1712–1721. 2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Neri M, Riezzo I, Pascale N, Pomara C and
Turillazzi E: Ischemia/reperfusion injury following acute
myocardial infarction: A critical issue for clinicians and forensic
pathologists. Mediators Inflamm. 2017(7018393)2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Zhu N, Cai C, Zhou A, Zhao X, Xiang Y and
Zeng C: Schisandrin B prevents hind limb from
ischemia-reperfusion-induced oxidative stress and inflammation via
MAPK/NF-κB pathways in rats. Biomed Res Int.
2017(4237973)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zheng Q, Huang YY, Zhu PC, Tong Q, Bao XY,
Zhang QH, Zheng GQ and Wang Y: Ligustrazine exerts cardioprotection
in animal models of myocardial ischemia/reperfusion injury:
Preclinical evidence and possible mechanisms. Front Pharmacol.
9(729)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu J, Wang H and Li J: Inflammation and
inflammatory cells in myocardial infarction and reperfusion injury:
A double-edged sword. Clin Med Insights Cardiol. 10:79–84.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yang CF: Clinical manifestations and basic
mechanisms of myocardial ischemia/reperfusion injury. Ci Ji Yi Xue
Za Zhi. 30:209–215. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gielis JF, Beckers PAJ, Briede JJ, Cos P
and Van Schil PE: Oxidative and nitrosative stress during pulmonary
ischemia-reperfusion injury: From the lab to the OR. Ann Transl
Med. 5(131)2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
González-Montero J, Brito R, Gajardo AI
and Rodrigo R: Myocardial reperfusion injury and oxidative stress:
Therapeutic opportunities. World J Cardiol. 10:74–86.
2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
He F and Zuo L: Redox roles of reactive
oxygen species in cardiovascular diseases. Int J Mol Sci.
16:27770–27780. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Li ZM, Xu SW and Liu PQ: Salvia
miltiorrhizaBurge (Danshen): A golden herbal medicine in
cardiovascular therapeutics. Acta Pharmacol Sin. 39:802–824.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li J, Zheng X, Ma X, Xu X, Du Y, Lv Q, Li
X, Wu Y, Sun H, Yu L and Zhang Z: Melatonin protects against
chromium(VI)-induced cardiac injury via activating the AMPK/Nrf2
pathway. J Inorg Biochem. 197(110698)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yu LM, Dong X, Xue XD, Zhang J, Li Z, Wu
HJ, Yang ZL, Yang Y and Wang HS: Naringenin improves mitochondrial
function and reduces cardiac damage following ischemia-reperfusion
injury: The role of the AMPK-SIRT3 signaling pathway. Food Funct.
10:2752–2765. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Xin DQ, Hu ZM, Huo HJ, Yang XJ, Han D,
Xing WH, Zhao Y and Qiu QH: Schisandrin B attenuates the
inflammatory response, oxidative stress and apoptosis induced by
traumatic spinal cord injury via inhibition of p53 signaling in
adult rats. Mol Med Rep. 16:533–538. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang W, Sun Z and Meng F: Schisandrin B
ameliorates myocardial ischemia/reperfusion injury through
attenuation of endoplasmic reticulum stress-induced apoptosis.
Inflammation. 40:1903–1911. 2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhao X, Xiang Y, Cai C, Zhou A, Zhu N and
Zeng C: Schisandrin B protects against myocardial
ischemia/reperfusion injury via the PI3K/Akt pathway in rats. Mol
Med Rep. 17:556–561. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yim TK and Ko KM: Schisandrin B protects
against myocardial ischemia-reperfusion injury by enhancing
myocardial glutathione antioxidant status. Mol Cell Biochem.
196:151–156. 1999.PubMed/NCBI
|
|
17
|
Steinberg GR and Schertzer JD: AMPK
promotes macrophage fatty acid oxidative metabolism to mitigate
inflammation: Implications for diabetes and cardiovascular disease.
Immunol Cell Biol. 92:340–345. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang M, Yang D, Gong X, Ge P, Dai J, Lin
L and Zhang L: Protective benefits of AMP-activated protein kinase
in hepatic ischemia-reperfusion injury. Am J Transl Res. 9:823–829.
2017.PubMed/NCBI
|
|
19
|
Daskalopoulos EP, Dufeys C, Beauloye C,
Bertrand L and Horman S: AMPK in cardiovascular diseases. Exp
Suppl. 107:179–201. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kanugula AK and Thodeti CK: AMP-activated
kinase 'Keaps' ischemia/reperfusion-induced necroptosis under
control. Int J Cardiol. 259:168–169. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Qi D and Young LH: AMPK: Energy sensor and
survival mechanism in the ischemic heart. Trends Endocrinol Metab.
26:422–429. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
da Costa RM, Rodrigues D, Pereira CA,
Silva JF, Alves JV, Lobato NS and Tostes RC: Nrf2 as a potential
mediator of cardiovascular risk in metabolic diseases. Front
Pharmacol. 10(382)2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Liu L, Locascio LM and Doré S: Critical
role of Nrf2 in experimental ischemic stroke. Front Pharmacol.
10(153)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Schmidlin CJ, Dodson MB, Madhavan L and
Zhang DD: Redox regulation by NRF2 in aging and disease. Free Radic
Biol Med. 134:702–707. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shen Y, Liu X, Shi J and Wu X: Involvement
of Nrf2 in myocardial ischemia and reperfusion injury. Int J Biol
Macromol. 125:496–502. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou F, Wang M, Ju J, Wang Y, Liu Z, Zhao
X, Yan Y, Yan S, Luo X and Fang Y: Schizandrin A protects against
cerebral ischemia-reperfusion injury by suppressing inflammation
and oxidative stress and regulating the AMPK/Nrf2 pathway
regulation. Am J Transl Res. 11:199–209. 2019.PubMed/NCBI
|
|
27
|
Fan X, Lv H, Wang L, Deng X and Ci X:
Isoorientin ameliorates APAP-induced hepatotoxicity via activation
Nrf2 antioxidative pathway: The involvement of AMPK/Akt/GSK3β.
Front Pharmacol. 9(1334)2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yang Q, Han L, Li J, Xu H, Liu X, Wang X,
Pan C, Lei C, Chen H and Lan X: Activation of Nrf2 by phloretin
attenuates palmitic acid-induced endothelial cell oxidative stress
via AMPK-dependent signaling. J Agric Food Chem. 67:120–131.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Mou Z, Feng Z, Xu Z, Zhuang F, Zheng X, Li
X, Qian J and Liang G: Schisandrin B alleviates diabetic
nephropathy through suppressing excessive inflammation and
oxidative stress. Biochem Biophys Res Commun. 508:243–249.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wu Y, Li ZC, Yao LQ, Li M and Tang M:
Schisandrin B alleviates acute oxidative stress via modulation of
the Nrf2/Keap1-mediated antioxidant pathway. Appl Physiol Nutr
Metab. 44:1–6. 2019.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cheng J, Wu Q, Lv R, Huang L, Xu B, Wang
X, Chen A and He F: MicroRNA-449a inhibition protects H9C2 cells
against hypoxia/reoxygenation-induced injury by targeting the
Notch-1 signaling pathway. Cell Physiol Biochem. 46:2587–2600.
2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Doridot L, Jeljeli M, Chêne C and Batteux
F: Implication of oxidative stress in the pathogenesis of systemic
sclerosis via inflammation, autoimmunity and fibrosis. Redox Biol.
25(101122)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Park JS, Leem YH, Park JE, Kim DY and Kim
HS: Neuroprotective effect of β-lapachone in MPTP-induced
parkinson's disease mouse model: Involvement of astroglial
p-AMPK/Nrf2/HO-1 signaling pathways. Biomol Ther (Seoul).
27:178–184. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen N and Ko M: Schisandrin B-induced
glutathione antioxidant response and cardioprotection are mediated
by reactive oxidant species production in rat hearts. Biol Pharm
Bull. 33:825–829. 2010.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ko KM and Chiu PY: Structural determinants
of schisandrin B which enhance mitochondrial functional ability and
glutathione status as well as heat shock protein expression in rat
hearts and H9c2 cells. Mol Cell Biochem. 276:227–234.
2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Lakota J: Molecular mechanism of
ischemia-reperfusion injury after myocardial infarction and its
possible targeted treatment. Int J Cardiol. 220:571–572.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Leong PK and Ko KM: Schisandrin B: A
double-edged sword in nonalcoholic fatty liver disease. Oxid Med
Cell Longev. 2016(6171658)2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Shao M, Yang W and Han G: Protective
effects on myocardial infarction model: Delivery of schisandrin B
using matrix metalloproteinase-sensitive peptide-modified,
PEGylated lipid nanoparticles. Int J Nanomedicine. 12:7121–7130.
2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Qiu Z, He Y, Ming H, Lei S, Leng Y and Xia
ZY: Lipopolysaccharide (LPS) aggravates high glucose- and
hypoxia/reoxygenation-induced injury through activating
ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2
cardiomyocytes. J Diabetes Res. 2019(8151836)2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Yao BJ, He XQ, Lin YH and Dai WJ:
Cardioprotective effects of anisodamine against myocardial
ischemia/reperfusion injury through the inhibition of oxidative
stress, inflammation and apoptosis. Mol Med Rep. 17:1253–1260.
2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Yang J, Yin HS, Cao YJ, Jiang ZA, Li YJ,
Song MC, Wang YF, Wang ZH, Yang R, Jiang YF, et al: Arctigenin
attenuates ischemia/reperfusion induced ventricular arrhythmias by
decreasing oxidative stress in rats. Cell Physiol Biochem.
49:728–742. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yang MY, Wang YB, Han B, Yang B, Qiang YW,
Zhang Y, Wang Z, Huang X, Liu J, Chen YD, et al: Activation of
aldehyde dehydrogenase 2 slows down the progression of
atherosclerosis via attenuation of ER stress and apoptosis in
smooth muscle cells. Acta Pharmacol Sin. 39:48–58. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Ndrepepa G: Myeloperoxidase-A bridge
linking inflammation and oxidative stress with cardiovascular
disease. Clin Chim Acta. 493:36–51. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Rohrbach S, Troidl C, Hamm C and Schulz R:
Ischemia and reperfusion related myocardial inflammation: A network
of cells and mediators targeting the cardiomyocyte. IUBMB Life.
67:110–119. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Vinten-Johansen J, Jiang R, Reeves JG,
Mykytenko J, Deneve J and Jobe LJ: Inflammation, proinflammatory
mediators and myocardial ischemia-reperfusion Injury. Hematol Oncol
Clin North Am. 21:123–145. 2007.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Wallert M, Ziegler M, Wang X, Maluenda A,
Xu X, Yap ML, Witt R, Giles C, Kluge S, Hortmann M, et al:
α-Tocopherol preserves cardiac function by reducing oxidative
stress and inflammation in ischemia/reperfusion injury. Redox Biol.
26(101292)2019.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Chen QM and Maltagliati AJ: Nrf2 at the
heart of oxidative stress and cardiac protection. Physiol Genomics.
50:77–97. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lv Y, Bing Q, Lv Z, Xue J, Li S, Han B,
Yang Q, Wang X and Zhang Z: Imidacloprid-induced liver fibrosis in
quails via activation of the TGF-β1/Smad pathway. Sci Total
Environ. 705(135915)2020.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Han B, Li S, Lv Y, Yang D, Li J, Yang Q,
Wu P, Lv Z and Zhang Z: Dietary melatonin attenuates
chromium-induced lung injury via activating the Sirt1/Pgc-1α/Nrf2
pathway. Food Funct. 10:5555–5565. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Jakobs P, Serbulea V, Leitinger N, Eckers
A and Haendeler J: Nuclear factor (Erythroid-Derived 2)-like 2 and
thioredoxin-1 in atherosclerosis and ischemia/reperfusion injury in
the heart. Antioxid Redox Signal. 26:630–644. 2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Hun Lee J, Shu L, Fuentes F, Su ZY and
Tony Kong AN: Cancer chemoprevention by traditional chinese herbal
medicine and dietary phytochemicals: Targeting nrf2-mediated
oxidative stress/anti-inflammatory responses, epigenetics, and
cancer stem cells. J Tradit Complement Med. 3:69–79.
2013.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Luo JF, Shen XY, Lio CK, Dai Y, Cheng CS,
Liu JX, Yao YD, Yu Y, Xie Y, Luo P, et al: Activation of Nrf2/HO-1
pathway by nardochinoid C inhibits inflammation and oxidative
stress in lipopolysaccharide-stimulated macrophages. Front
Pharmacol. 9(911)2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yang S, Chou G and Li Q: Cardioprotective
role of azafrin in against myocardial injury in rats via activation
of the Nrf2-ARE pathway. Phytomedicine. 47:12–22. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Chiu PY, Chen N, Leong PK, Leung HY and Ko
KM: Schisandrin B elicits a glutathione antioxidant response and
protects against apoptosis via the redox-sensitive ERK/Nrf2 pathway
in H9c2 cells. Mol Cell Biochem. 350:237–250. 2011.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Potenza MA, Sgarra L, Nacci C, Leo V, De
Salvia MA and Montagnani M: Activation of AMPK/SIRT1 axis is
required for adiponectin-mediated preconditioning on myocardial
ischemia-reperfusion (I/R) injury in rats. PLoS One.
14(e0210654)2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zhang Y, Wang Y, Xu J, Tian F, Hu S, Chen
Y and Fu Z: Melatonin attenuates myocardial ischemia-reperfusion
injury via improving mitochondrial fusion/mitophagy and activating
the AMPK-OPA1 signaling pathways. J Pineal Res.
66(e12542)2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Duan J, Guan Y, Mu F, Guo C, Zhang E, Yin
Y, Wei G, Zhu Y, Cui J, Cao J, et al: Protective effect of butin
against ischemia/reperfusion-induced myocardial injury in diabetic
mice: Involvement of the AMPK/GSK-3β/Nrf2 signaling pathway. Sci
Rep. 7(41491)2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Tanaka M, Kishimoto Y, Sasaki M, Sato A,
Kamiya T, Kondo K and Iida K: Terminalia bellirica (Gaertn.) Roxb.
Extract and gallic acid attenuate LPS-induced inflammation and
oxidative stress via MAPK/NF-κB and Akt/AMPK/Nrf2 pathways. Oxid
Med Cell Longev. 2018(9364364)2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Hou X, Fu M, Cheng B, Kang Y and Xie D:
Galanthamine improves myocardial ischemia-reperfusion-induced
cardiac dysfunction, endoplasmic reticulum stress-related
apoptosis, and myocardial fibrosis by suppressing AMPK/Nrf2 pathway
in rats. Ann Transl Med. 7(634)2019.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Huang S, Li H and Ge J: A cardioprotective
insight of the cystathionine γ-lyase/hydrogen sulfide pathway. Int
J Cardiol Heart Vasc. 7:51–57. 2015.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Peake BF, Nicholson CK, Lambert JP, Hood
RL, Amin H, Amin S and Calvert JW: Hydrogen sulfide preconditions
the db/db diabetic mouse heart against ischemia-reperfusion injury
by activating Nrf2 signaling in an Erk-dependent manner. Am J
Physiol Heart Circ Physiol. 304:H1215–H224. 2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Fang XX, Wang H, Han D, Xie E, Yang X, Wei
J, Gu S, Gao F, Zhu N, Yin X, et al: Ferroptosis as a target for
protection against cardiomyopathy. Proc Natl Acad Sci USA.
116:2672–2680. 2019.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23(101107)2019.PubMed/NCBI View Article : Google Scholar
|
